mlsanityData to 14 Oct 2026

Deep Inverse Reinforcement Learning for Structural Evolution of Small Molecules

arXiv 2008.11804 ↗First posted 24 Jul 2020q-bio.BM cs.AI cs.LGcited by 2

On the map: Offline RL and imitation learning from data → Inverse reinforcement learning

Abstract (arXiv)

The size and quality of chemical libraries to the drug discovery pipeline are crucial for developing new drugs or repurposing existing drugs. Existing techniques such as combinatorial organic synthesis and High-Throughput Screening usually make the process extraordinarily tough and complicated since the search space of synthetically feasible drugs is exorbitantly huge. While reinforcement learning has been mostly exploited in the literature for generating novel compounds, the requirement of designing a reward function that succinctly represents the learning objective could prove daunting in certain complex domains. Generative Adversarial Network-based methods also mostly discard the discriminator after training and could be hard to train. In this study, we propose a framework for training a compound generator and learning a transferable reward function based on the entropy maximization inverse reinforcement learning paradigm. We show from our experiments that the inverse reinforcement learning route offers a rational alternative for generating chemical compounds in domains where reward function engineering may be less appealing or impossible while data exhibiting the desired objective is readily available.

Key facts. Cited by 2 papers in the map (data through 14 Oct 2026). Placed in Inverse reinforcement learning, one of 13 directions in Offline RL and imitation learning from data. Builds on 22 of its 44 references that are in the map. First posted on arXiv 24 Jul 2020.

Builds on

22 of 44 references.

Closest ancestors · 1

Same direction, newest first

  1. 2018A Survey of Inverse Reinforcement Learning: Challenges, Methods and Progress18 Jun

Other references · 21

  1. 2017Proximal Policy Optimization Algorithmscited by 15,215
  2. 2014Neural Machine Translation by Jointly Learning to Align and Translatecited by 4,548
  3. 2015Trust Region Policy Optimizationcited by 2,580
  4. 2015High-Dimensional Continuous Control Using Generalized Advantage Estimationcited by 2,026
  5. 2016Generative Adversarial Imitation Learningcited by 1,597
  6. 2015Show, Attend and Tell: Neural Image Caption Generation with Visual Attentioncited by 1,423
  7. 2017Towards Principled Methods for Training Generative Adversarial Networkscited by 464
  8. 2016Guided Cost Learning: Deep Inverse Optimal Control via Policy Optimizationcited by 406
  9. 2016SeqGAN: Sequence Generative Adversarial Nets with Policy Gradientcited by 376
  10. 2019Stabilizing Transformers for Reinforcement Learningcited by 270
  11. 2017Molecular De Novo Design through Deep Reinforcement Learningcited by 267
  12. 2015Maximum Entropy Deep Inverse Reinforcement Learningcited by 176
9 more
  1. 2016A Connection between Generative Adversarial Networks, Inverse Reinforcement Learning, and Energy-Based Modelscited by 168
  2. 2017Deep Reinforcement Learning for De-Novo Drug Designcited by 161
  3. 2019Generalization in Generation: A closer look at Exposure Biascited by 123
  4. 2017Objective-Reinforced Generative Adversarial Networks (ORGAN) for Sequence Generation Modelscited by 117
  5. 2015Inferring Algorithmic Patterns with Stack-Augmented Recurrent Netscited by 76
  6. 2016Protein-Ligand Scoring with Convolutional Neural Networkscited by 57
  7. 2017ChemGAN challenge for drug discovery: can AI reproduce natural chemical diversity?cited by 21
  8. 2016Modelling Chemical Reasoning to Predict Reactionscited by 8
  9. 2020Multi-View Self-Attention for Interpretable Drug-Target Interaction Predictioncited by 3

Built on by

Cited by year

Citing papers per year: 2023: 1; 2024: 0; 2025: 1.

2 papers.

Similar, not cited

Close in wording, no citation either way

  1. 2024It Takes Two to Tango: Directly Optimizing for Constrained Synthesizability in Generative Molecular Design
  2. 2025Guiding Generative Models to Uncover Diverse and Novel Crystals via Reinforcement Learning
  3. 2024Diversity-Aware Reinforcement Learning for de novo Drug Design
  4. 2024Mol-AIR: Molecular Reinforcement Learning with Adaptive Intrinsic Rewards for Goal-directed Molecular Generation
  5. 2024ACEGEN: Reinforcement learning of generative chemical agents for drug discovery
  6. 2024Quantum-inspired Reinforcement Learning for Synthesizable Drug Design
  7. 2026Reinforcement Learning on the Discrete Composition Channel of a Crystal Generator: Validated Gains and Reward Hacking
  8. 2025ReACT-Drug: Reaction-Template Guided Reinforcement Learning for de novo Drug Design